Catalent
CTLT
#1595
Rank
S$14.40 B
Marketcap
$79.38
Share price
-0.35%
Change (1 day)
76.34%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.72

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.73. In 2022 the company made an earnings per share (EPS) of $3.04 a decrease over its 2021 EPS that were of $4.38.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.72-156.59%
2022$3.04-30.58%
2021$4.3879.67%
2020$2.44114.12%
2019$1.14-15%
2018$1.3475.44%
2017$0.76-22.97%
2016$0.99-59.56%
2015$2.45282.05%
2014$0.64-378.2%
2013-$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.06-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.00-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.89 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.56-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA